Compare GEHC & ROP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | ROP |
|---|---|---|
| Founded | 1892 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 34.1B |
| IPO Year | 2022 | 2002 |
| Metric | GEHC | ROP |
|---|---|---|
| Price | $60.58 | $367.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $88.38 | ★ $492.60 |
| AVG Volume (30 Days) | ★ 4.3M | 812.6K |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | 0.24% | ★ 1.02% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | 0.85 | ★ 4.87 |
| Revenue | ★ $20,625,000,000.00 | $7,902,500,000.00 |
| Revenue This Year | $7.12 | $8.80 |
| Revenue Next Year | $4.45 | $6.73 |
| P/E Ratio | $72.93 | ★ $72.92 |
| Revenue Growth | 4.84 | ★ 12.26 |
| 52 Week Low | $58.75 | $305.96 |
| 52 Week High | $89.77 | $564.68 |
| Indicator | GEHC | ROP |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 60.15 |
| Support Level | $60.17 | $344.54 |
| Resistance Level | $65.83 | $384.00 |
| Average True Range (ATR) | 1.89 | 10.86 |
| MACD | -0.33 | -0.17 |
| Stochastic Oscillator | 18.40 | 84.43 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.